A growth hormone releasing peptide that stimulates natural GH secretion. Works synergistically with GHRH analogues for enhanced growth hormone release.
GHRP-2 is a potent GH secretagogue used in research and as a GH-deficiency diagnostic. It is typically dosed by subcutaneous injection and is commonly studied alongside GHRH analogs for synergistic GH release.
GHRP-2 (pralmorelin) is a synthetic hexapeptide agonist of the ghrelin receptor (GHS-R1a). It stimulates pulsatile growth hormone release from the anterior pituitary and can transiently elevate cortisol and prolactin.
Not FDA-approved in the US. Elevations in cortisol and prolactin can occur.
Sermorelin is a synthetic peptide that functions as a growth hormone-releasing hormone analog, stimulating the body's natural production and release of growth hormone. It was initially developed for treating growth hormone deficiency in both children and adults.
100-200 mcgIpamorelin
Ipamorelin is a synthetic protein fragment that stimulates the body's natural growth hormone release by mimicking ghrelin. It is being researched for its potential to improve body composition and aid in tissue repair.
200-300 mcgIbutamoren Mesylate
MK-677 is an orally active, non-peptide compound that functions as a ghrelin receptor agonist and growth hormone secretagogue, leading to increased secretion of growth hormone and insulin-like growth factor 1, potentially enhancing body composition, sleep quality, and bone density.
12.5-25 mgGrowth Hormone Releasing Peptide-6
A potent growth hormone secretagogue that stimulates the pituitary gland. Increases appetite and GH levels with potential effects on body composition.
100-300 mcg